NCT02099006View on ClinicalTrials.gov

Novel Topical Therapies for the Treatment of Genital Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Female Genital Diseases
Interventions
DRUG

Amitriptyline

Topical application of the drug at a 2% concentration in combination with 2% Baclofen

DRUG

Baclofen

Used topically at 2% concentration in combination with 2% amitriptyline

DRUG

Ketoprofen

To be applied topically at a 10% concentration

DRUG

Ketamine

To be applied topically at a 10% concentration

DRUG

Loperamide

To be applied topically at a 5% concentration

DRUG

Gabapentin

To be applied topically at a 6% concentration

DRUG

placebo

Compounding base to be used alone as a placebo

Trial Locations (1)

14642

University of Rochester, Rochester

All Listed Sponsors
collaborator

Mae Stone Goode Foundation

OTHER

lead

University of Rochester

OTHER

NCT02099006 - Novel Topical Therapies for the Treatment of Genital Pain | Biotech Hunter | Biotech Hunter